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In preceding papers (1-3) it has been shown that heightened resistance to 
certain  tumor homografts in mice can be transferred  to secondary hosts by 
lymph node cells,  but not by serum.  Similar  results have  been reported  by 
Billingham,  Brent,  and Medawar (4),  with resistance  to homografts of skin. 
Nevertheless antibodies against the foreign tissue have been repeatedly dem- 
onstrated  in  the  serum  of mice in  which  homografts have  regressed.  Gorer 
(5-7)  has  shown that  erythrocytes which  share  antigens  in common with a 
regressed tumor are agglutinated by antibody in the serum, and similar hem- 
agglutinins have been recently reported after sloughing of skin homografts (8). 
Corer  (9)  working  with  leukemic  cells,  and  Billingham  and  Sparrow  (10) 
working with skin epithelial cells, have also shown that serum antibody can 
combine with these ceils in vitro and inhibit their growth on subsequent trans- 
plantation into susceptible hosts. 
The relation between serum antibody and graft resistance is the subject of 
further investigation in the present work. Particular attention  has been paid 
to the hemagglutinating  antibody produced in C57BR/a mice in response to 
homografts of a  sarcoma, Sarcoma 1 (SA1). The production of this antibody 
has been followed in actively immunized  mice,  and also in mice which have 
received lymph node and  spleen cells from immunized  donors.  Comparisons 
have been made between antibody titres and resistance to test grafts of tumor. 
The  experiments  have  been  extended  to  a  study  of  the  immunological 
response in  mice  which  have  been  treated  with  lyophilized  or frozen  tissue 
preparations.  The growth of tumor homografts is enhanced by this pretreat- 
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ment, in certain  combinations  of tumor and host.  Previous  findings  on this 
subject  have  been  reviewed  by Snell  (11,  12).  The report  of  Kaliss  and Molo- 
rout (13)  that  hemagglutinating  antibody is elicited  by this  pretreatment, 
together  with  findings  of  remarkably high  titres  of  hemagglutinin  in  pretreatcd 
mice bearing  progressively  growing  tumor homografts  (6, 14), suggested 
that  use could  be made of the pretreatment  to separate  hemagglutinin  pro- 
duction  from graft  resistance.  The production  of  hemagglutinin,  the response 
of the regional  lymph nodes to homografts,  and the  protection  conferred  by 
non-pretreated  lymph node cells,  have accordingly  been investigated  in  pre- 
treated mice. 
Materials and Methods 
The strains of  mice, the  transplantable tumors, and  the procedures used for  transfer- 
ring lymph nodes have  been described  in the  previous paper  (3). 
Serological Methods.--For agglutination of erythrocytes the technique of Gofer and Mi- 
kulska  (8)  was  followed.  The  sera  were  diluted  in  saline  containing  2  per  cent 
dextran  (average molecular weight 80,000). The dextran was dissolved directly in the saline 
and stored at 4°C. without being autoclaved. The red cells were suspended in suitably ab- 
sorbed human serum. In view of the variation in potency noted by Gofer,  a  single sample 
of serum was used throughout the present work. In other respects the agglutination tech- 
nique  is  the  same  as  that  used  in  rhesus  typing. 
Methods Used .for Enhancing the  Growth of  Tumor Homografls.--Two procedures  were 
used for enhancing the growth of tumor homografts by pretreatment of the host with tis- 
sue preparations. Following Kaliss  and  Snell  (15),  lyophiliy~d  A  splenic  tissue was  sus- 
pended in saline and injected intraperitoneally in 6  equal amounts at intervals of 2,  2, 3, 
2, and 2 days, each mouse receiving a total of 6 nag. lyophilized  tissue. Following Sndl (16), 
frozen Sarcoma 1 (SA1) was homogenized,  suspended in saline, and centrifuged for 1 hour 
at  16(}00 g.  Four equal amounts of the supernatant fluid were injected intraperitoneally, 
at intervals of 3, 4, and 3 days, each mouse receiving the equivalent of 40 mg. lyophilized 
tissue. The pretreated  mice were of the C57BL/6Ks,  C57BR/a, and B10.D2 strains. SA1 
was  employed as  the  test  tumor after  pretreatment. Thus an hr-g~ tumor was  tested  in 
//-2  d or //_gk hosts; this is the combination which has been most  fttUy investigated (12), 
and in which pretreatment has been found to  be most  effective. 
Experimental 
Serum  Cytotoxin  against  SA1 
An  isoantibody  against  SA1  was  demonstrated  by  a  modification  of  the 
method  of Gorer  (9).  An example  of cytotoxic  activity is shown  in Table  I 
in  which  serum  taken  from  C57BR/a  mice  5  days  after  a  second  injection 
of SAI was under test. 
Portions of a  suspension of SA1, containing 180,000 ceils 0.1  nil., were incubated with 
equal volumes of normal C57BR/a serum or the serum under test, for 30 minutes at 37°C. 
The suspensions of  cells in normal and test serum were implanted subcutaneously in the 
opposite flanks of  5  C57BR/a and 5 A hosts,  at a  dosage  of 0.1  ml./implantation. Eight 
days later the tumor growths were  excised  and weighed,  and the paired weights of  those 
from  each  host  are  shown  in  the  table. N.  A.  MITCHISON AND  0.  L.  DUBE  181 
Greater growth of both antiserum-treated  and control cells were found in 
the susceptible hosts. Growths from ceils treated with antiserum were smaller 
than  the  controls  treated  with  normal  serum,  although  the  difference  was 
slight.  The effect has been observed repeatedly, but with findings  that "were 
not strictly quantitative.  Sera from mice grafted only once with tumor were 
particularly variable. 
Hemagglutinin Production in C57BR/a Mice Receiving SA1 
Sera  from  C57BR/a  mice immunized  with  SA1  regularly and  repeatedly 
agglutinated the red blood cells of the strain of origin of the tumor, so attention 
was centered on the role of this type of antibody in graft breakdown. Curves 
of hemagglutinin  production following  trocar implantation  of SA1  are given 
in  Fig.  1,  the geometric means of the titres of individual  sera being shown. 
TABLE I 
The Effect on Their Subsequent  Gro~tk  of Incubation  of SAI Cells with Serum from Immunized 
C57BR/a Mice 
Weight of tumor growths after 8 days in milligrams. 
In 3wsceptible (,4) tlos~ 
Cells incubated with antiserum (right flank) .................  130 I 100 I  64149  1 50 
Cells incubated with normal serum (left flank) ...............  152  101  108  66  69 
Is Nan-S~¢cptiblo (C57B.P./a) Hosts 
CeUs incubated with antiserum (right flank) .................  O[  710  8[2 
Cells incubated with normal serum (left flank) ...............  2  49  7  11  7 
The  response  shown in  previously immunized  mice  was obtained  17  weeks 
after a first implantation  of SA1. The peak of hemagglutinin  production was 
reached at 15 days, or later,  after the first implantation  of tumor,  and at  7 
days after  the  second.  The  peaks  were thus  reached  after  the  immunizing 
homografts had  all  died: the median survival time of a  first graft of SA1 in 
C57BR/a mice was 10.8 days, and of a second 5.5 days (3). 
Hemagglutinin Production by the Regional Lymph Nodes and Spleen 
The ability of the lymph node and spleen cells of immunized mice to trans- 
fer hemagglutinin production into secondary hosts was next tested. 
In two series of experiments  regional lymph nodes snd spleens were taken at  5 day in- 
tervals after implantation of C57BR/a  donors  with SA1  by trocar.  At each interval  the 
lymph nodes were minced and transferred to 4 C57BR/a hosts, at a dosage of 4 donors  per 
host, and the spleens were transferred to 4 hosts at a dosage of 1 donor per host. The hosts 
were bled  at intervals of 1, 4, 8, 15, and 30 days after transfer, and the sera titrated  for 
hemagglutinin. 1024 
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Antibody was  duly found, the  geometric  means of  the  individual titres 
being shown in Fig. 2. 
The appearance  of antibody in the serum of the hosts can hardly be due to 
transfer of preformed  antibody in the lymph node or spleen cells, in view of 
the course of the rise in titre, and the height reached. Titres rose consistently 
between 1 and 4 days, and occasionally between 4 and 8 days after transfer 
of cells. Indeed the fact is shown below in Fig. S that after transfer of cells 
from "hyperhnmunized" donors, antibody titres in the serum of the host did 
not begin  to decline for more than 8 days. This may be compared  with the 
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FzG. 1.  Hemagglutinin production in CSTBR/a mice in response to implantation of SA1. 
Geometric  mean  titres:  Primary  response  (a)  repeated  bleedings from  6  individuals; 
(b) repeated bleedings from 6 individuals, another series; (~) samples of 6 individuals killed 
at intervals, Secondary response from repeated bleedings of 5  individuals. 
half-life of isohemagglutinin in the mouse, which is approximately 2 days (17)" 
On  the  other hand,  antibody appeared  more  rapidly than in  actively im- 
munized mice. As with transfer of heightened resistance  to homografts (3), 
the evidence therefore indicates that the transferred cells continued to function 
in their host, or possibly  that an antibody producing  mechanism was trans- 
ferred into the cells of the host. 
Peak activity was reached earlier by the regional lymph nodes than by the 
spleen,  in  both  series. This  can be  accounted for by the direct lymphatic 
drainage from the homograft to the regional lymph nodes.  Greater activity 
in the regional lymph nodes than in the spleen is also evident. 
The highest titres of hemagglufinin were produced by lymph nodes trans- 
ferred 10 to 15 days after the donors had been  implanted with tumor. This N.  A.  MITCHISON  AND  O.  L.  DUBE  183 
is later than the period (5 to 10 days), reported in the previous paper  (3), 
during which the nodes are most effective in conferring heightened resistance to 
homografts. 
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FIG.  2.  Hemagglutinin  production  in  C57BR/a  hosts  after  receiving lymph  node  and 
spleen cells transferred from immunized donors. 
Comparison of the Power of Lymph Node Cells to  Transfer Heightened Graft 
Resistance and Eemagglutinin Production 
The separation in  time of graft resistance and hemagglutinin production 
in the regional lymph nodes is shown more clearly in the following experiment. 
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A single group of C57BR/a  mice were implanted by trocar with SA1. 6 days later  the 
regional lymph nodes were taken from half the group, and transferred to  mice of the same 
strain, at a dosage of 4 donors/host. Lymph nodes were later transferred from the  second 
half of the group, 14 days after tumor implantation. Both groups of hosts were bled 4 days 
after the  transfer, and  their  serum hemaggiutinin titrated.  After bleeding they were im- 
planted subcutaneously with 1 X  106 ascitic cells of SA1 suspended in 0.1 mi. Ringer, and 
the tumors weighed 8 days later. An equal number of untreated  mice were implanted with 
each group as a control. 
The  mean  titres  of hemagglutinin  and  the  mean  weights  of  the  test  im- 
plantations  are  shown in Table II. The nodes transferred  14  days after the 
immunizing tumor transfer produced slightly more hemagglutinin than those 
transferred  after 6  days.  Although  conferring  some heightened  resistance  to 
the test grafts of tumor, they conferred much less than did the 6  day nodes, 
TABLE II 
Comparison of Power of Lymph Node Cdls to Transfer Heigkteneg Graft Resistance and 
Hemagglutinin Producgon 
Implantation  of SA1 into C57BR/a mice. 
Interval between implantation 
of donors and transfer of cells. 
days 
6 
(Control) 
14 
(Control) 
No. of hosts 
10 
10 
10 
10 
Log  s hemagglutinin titre* 
in hosts after 4 days 
(mean and standard 
deviation) 
4.6  4-  1.7 
5.7  4-  2.0 
8 day old  test tumor grafts: 
mean weight and standard 
deviation in nag. 
2.3  4-  4.3 
102.6  4-  29.3 
127.5  4-  87.3 
254.1  -4-  81.5 
* Serial number of last tube showing agglutination. 
as judged either by the absolute weights of the test grafts, or by comparison 
with the weight of the grafts in the controls. The conclusion follows that more 
than one factor is produced by the  regional lymph nodes in response to im- 
plantation of SA1. The agent which is mainly responsible for graft breakdown 
must be produced earlier than the hemagglutinating antibody. 
The Secondary  Hemagglutinin  Response  in  Hosts  of Transferred 
Lymph  Node  Cells 
An  experiment was  carried  out  to  test  for more  prolonged  effects of  the 
transferred  cells.  At  9  to  12  weeks after transfer  of minced  regional  lymph 
nodes and  spleens from donors implanted by trocar  15  days before transfer, 
groups  of  C57BR/a  hosts  were  implanted  by  trocar  with  SA1.  They  were 
bled before implantation,  and at  7  and  17  days postimplantation.  The indi- 
vidual hemagglutinin responses are shown in Fig. 3, together with the normal 
primary and secondary responses to SA1 taken from Fig. 1. If the transferred N.  A.  MITCHISON  AND  O.  I,.  DUBR  185 
material had survived for this length of time in the hosts, or if the hosts had 
been actively immunized, responses similar to the normal secondary response 
were to be expected. However, if the material had disappeared without immu- 
nizing the hosts, a normal primary response was to be expected. The observed 
responses resembled for the most part the primary type, indicating  that the 
transferred material had been lost.  But certain  individuals  showed  the high 
titres  at  7  days postimplantations,  characteristic  of the  secondary response, 
and  others  showed  an  intermediate  response.  Some  transferred  antibody- 
producing mechanism may have persisted in these mice, or more likely, active 
immunity may have been produced by transferred antigen.  Similar prolonged 
....... --0 
H  emaCJglutinla  P- -- - 
tlter  /( Normal 
1024  / ~ secondary 
/~)  response  / 
256  ///"  ~""=~ 
primary 
l  ~  ~  response 
:  i~ 
0  i 7  17' 
Interval ~fter  tumor  implantation in  days 
Fro. 3.  Responses to a challenging implantation of SAI, of individual C57BR/a  mice 
which have previously received lymph  node cells from immunized donors. 
effects of  transferred  lymph  node  cells  have  been  reported  in  the  previous 
paper (3), as judged by heightened graft resistance. 
Hemagglutinin Production during Tumor Growth in Pretreated Mice 
The  course  of hemagglutinin  production  was  followed  in  mice pretreated 
with frozen or lyophilized tissue before receiving a  homograft. 
Six C57BR/a  mice were pretreated  by injection of lyophilized spleen, and  implanted 
with SA1 by troear subsequently. Six mice similarly treated  with  the  tissue preparation 
were retained as controls and not injected; and a further  six C57BR/a controls were im- 
planted with the tumor, but not pretreated. The three groups were bled together at 10 day 
intervals,  commencing immediately  before tumor  implantation.  Hemagglutinin  against 
red  blood cells was titrated  in  the  individual sera. 186  ]3/M'UNOLOGICAL RESPONSE  TO  TT/~OR  TRANSPLANTS.  II 
The efficacy of the pretreatment was demonstrated by an  additional con- 
trol group which  was  pretreated  and implanted  together with these experi- 
mental mice: out of 12 mice tested, all succumbed to the tumor. 
An additional series of hemagglutinin titrations was carried out with C57- 
BL/6Ks mice.  The  same  procedure was  followed, except that  the  pretreat- 
ment was  carried out with SA1  supematant  instead of A  spleen; pretreated 
and implanted controls showed a  mortality of 6 out of 6. 
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FIO. 4, Hemagglutinin  production in response to implantation of SA1, in C57BR/a mice 
after pretreatment with lyophilized A spleen, and in C57BL/6Ks mice after pretreatment 
with frozen-thawed  SA1. 
The geometric means of the individual  titres of hemagglutinin are shown 
in Fig. 4.  Pretreated mice bearing tumors were not bled later than  20 days 
after tumor implantation, since most had died before the 13th day. The groups 
which were implanted but not treated with tissue preparations gave the ex- 
pected hemagglutinin response, maximum titres being reached 20 days after 
implantation.  When  given alone,  the lyophilized and  frozen  tissue  prepara- 
tions elicited a  marked  production of hemagglutinin,  which  declined slowly 
after  the  completion of  the  injections.  Consequently at  the  time  when  the 
pretreated  mice  were  implanted  with  tumor,  hemagglutinating  antibody 
was circulating in their blood, at a  titre similar to that found in normal mice 
giving the sloughing off of a  homograft. Furthermore, as the tumor grew pro- 
gressively the  titre  of hemagglutinin  rose,  and  finally reached  a  far higher N.  A.  MITCHISON  AND  O.  L.  DUBE  187 
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level than that normally found during the sloughing of a  first graft of tumor. 
The pretreatment therefore certainly does not impair the ability to produce 
hemagglutinating antibody. 
Hemagglutinin  Production  after  Transfer  of Lymph  Node  Cells 
from Pretreated Mice Bearing a Tumor 
The regional  lymph  nodes  can  be  shown  to  participate  in  hemagglutinin 
production in pretreated mice bearing a  tumor. 
C57BR/a mice were pretreated with lyophillzed A spleen and implanted with SA1. 18 
days later the regional lymph nodes and spleens were transferred to mice of the same strain, 
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FIG. 5. The effect  of pretreatment  of the donors with lyophilized tissue, in increasing 
hemagglutinin production by cells transferred into  secondary hosts (B10.D2 mice im- 
planted with SA1). 
the lymph nodes to 6 hosts at a  dosage of 4  donors per host, and the spleens to 6 hosts at 
a  dosage of  1 donor per host. The efficacy of the pretreatment was shown by a  mortality 
of 6 out of 9 control mice pretreated with the donors and implanted at the same time. Nodes 
and spleens were also  transferred as a  control out of normal  C57BR/a donors bearing  18 
day  old growths  of  SA1, at  the same dosage. The hosts were bled at  intervals of  1, 4,  8, 
15,  and  30 days  after transfer, and  the individual sera  titrated for hemagglutin~n~ 
The geometric means of the individual titres are shown in Fig. 5. No hemag- 
glutinin production was detected in the hosts of the transferred control cells, 
possibly  because  of weak  implants  of immunizing  SA1  that  had  given rise 
to  only slight  growths  in  the donors.  But both  the nodes and  spleens from 
the pretreated and implanted donors gave rise to high and persistent titres of 
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The  Duration  of  Hemagglutinin  Production  after  Transfer  of 
Lymph Node Cells to Foreign  Hosts 
A  test  of the  duration  of hemagglutinin  production  after  transfer  of ceils 
into  foreign  hosts  was made possible  by the  high  activity of ceils from pre- 
treated  and  implanted  donors.  The  purpose  of  this  experiment  was  similar 
to that of the tests of the duration  of heightened graft resistance after trans- 
fer  of  ceils  into  foreign  hosts,  reported  in  the  accompanying paper  (3):  to 
test  whether  the  transferred  material  can  be  destroyed  by  the  homograft 
reaction of the host. 
B10.D2  donors  were  pretreated  with  lyophilized  A  spleen and  inoculated  with  SA1. 
17 days later  the regional lymph nodes were  transferred  to 6  B10.D2 hosts,  and also to 
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FXO. 6. Hemagglutinin production in BI0.D2 and  C57BL/i0-B-Z  ~ hosts after transfer 
of lymph node ceils from pretreated  and  implanted  B10.D2  donors. 
6 C57BL/10-H-2  ~ hosts, at a dosage of 4 donors per host. The hosts were bled after the same 
intervals  as in the previous  experiment, and the geometric means  of the individual  titres 
are shown in Fig. 6. 
As has been shown for heightened graft resistance, the production of hemag- 
glutinin  declined  more  rapidly,  following  transfer  of  lymph  node  cells  into 
foreign hosts. The hypothesis that the transferred material is itself susceptible 
to a  homograft reaction was therefore confirmed. 
Failure of Lymph Node Cells Donated by Pretreated Mice Bearing 
a  Tumor to Confer Heightened Resistance 
A group  of C57BL/6Ks  donors were pretreated  with SA1 supematant  and  implanted 
by trocar with SA1. These  mice were pretreated  and implanted  together  with a  group  of 
controls already referred to, which showed a mortality of 6 out of 9. A control group of nor- 
real C57BL/6Ks  donors were also implanted with SA1 at the same time.  10 days after im- 
plantation  the regional lymph nodes were transferred from both groups of donors into fresh 
mice of the same strain,  at dosages of 4, 2, and 1 donor per host. The hosts were then in- N.  A.  MITCHISON AND  O.  L.  DUBE  189 
jected subcutaneously with 1 X  106 ascitic cells d  SA1, suspended in 0.1  ml. Ringer, and 
the tumor growths were weighed after 8 days. Untreated mice of the same strain,  and mice 
actively immunized  with SA1 were also implanted, as controls. 
The weights of the test tumor growths,  shown in Table HI, indicate  that 
the larger doses of ceils from non-pretreated and implanted donors conferred 
heightened  resistance  to  the  tumor,  as expected.  The  smaller doses  of cells 
from the pretreated implanted donors had no significant effect,  while at  the 
largest dose of 4 donors per host they appeared to enhance the growth of the 
tumor.  This  enhanced  growth  can  be accounted  for: nodes from pretreated 
and implanted donors have been shown to produce hemagglutinin after trans- 
TABLE HI 
Failure of Lymph Node Cells from Pretreatod and Implanted Donors to  Confer Immunity 
Implantation  of SA1 into C57BL/6Ks mice; pretreatment  with SA1 supernatant. 
Treatment of donors 
Pretreated: 
Implanted with SAI.. 
Not pretveated: 
Implanted with SAI.. 
Untreated controls. 
Controls actively immunized with SA1.. 
No. of  8 day old SAI test 
donors  No. of  tumors: mean 
per host  hosts  weight and standard 
deviation in mg. 
4  "i 
2 
1 
124.8 -4- 64.6 
42.2  :t:  27.5 
88.9  -4- 87.3 
1.8  fl=  2.8 
10.3 -4-  8.4 
[  80.9=t= 86.1 
46.0  4-  12.1 
0.2  q-  0. I 
fer; and  hemagglufinating serum has been shown  to enhance  growth  of the 
tumor (3). 
Protection of Pretreated  Mice by Lymph Node Cells 
from  Immunized  Donors 
The  failure  of lymph  node  cells  from pretreated  and  implanted  mice  to 
confer heightened  resistance  to  the  tumor indicated  that  the normal ability 
of lymphoid tissue  to protect against a  tumor homograft is blocked in pre- 
treated mice. The ability of lymph nodes from immunized donors to protect 
pretreated mice against the tumor was next tested. 
Use was made of the experimental design employed by Billingham, Brent, and Medawar 
(18), in their demonstration of homograft breakdown in mice with  actively acquired toler- 
ance after transfer  of lymph node cells. Groups of normal  C$TBR/a and  B10.D2 mice 190  ~NOLOGICAL  RESPONSE  TO  TUMOR  TRANSPLANTS.  II 
were implanted with SA1, and after 9 days their regional  lymph nodes  were transferred  to 
pretreated  mice of the same strain.  The hosts were implanted  on the same day with test 
grafts of SA1 by trocar,  together with control groups which had also been pretreated,  but 
which  had  not  received  lymph  node  ceils. 
The  results  of  this  experiment  are  shown  in  the  first  and  second  rows  of 
Table  IV.  In  all  series  tested,  the  lymph  node  ceils  transferred  out  of  im- 
munized donors conferred protection  on their pretreated  hosts. 
A  gradual  loss of the protection  conferred by transferred  node  ceils  could 
be demonstrated,  parallel  to the gradual loss of adoptive immunity described 
in  the  previous  paper  (3).  Some  of  the  protected  mice  were  left  for an in- 
TABLE IV 
Immunity Conferred by Transferred Lymph Node Cells on Pretreated Mice 
Mortality from test inoculation of SA1. 
Mice received pretreatment plus:  C57BR/a 
Test implantation  alone ....................  I  12/12 
Lymph node cells from immunized donors 
test implantation ........................  0/10 
Lymph node cells from normal donors -{- test 
implantation ........................... 
Lymph node cells from normal donors +  prior 
tail implantation  +  test implantation .....  -- 
Prior tail implantation  -{- test implantation...  -- 
Lymph node cells from pretreated  donors  "4- 
prior tail implantation  +  test implantation.  -- 
C  PBR/a 
/IO 
/6 
/6 
/s 
/6 
C57Bl~a 
o/s 
0/6 
4/6 
5/5 
BI0.D 
0/5 
616 
4/5 
415 
415 
All host strains  not susceptible to SA1; all hosts  pretreated  with lyophilized A spleen. 
Each column refers to a group of mice pretreated  at the same time; a separate  control was 
included in each group, since the control mortalities were not homogeneous. 
terval  after  their  test  implantation,  and  were  then  reimplanted  with  SA1. 
The  second  graft  of tumor  grew  progressively and  killed  the  host  in  a  pro- 
portion  of cases,  as  shown  in  Table  V.  The  data  show signs  of an  irregular 
increase  in  mortality  as  the  interval  between  the  first  and  second  tests  is 
increased.  This  experiment  is  made  possible  by  the  very  long  duration  of 
susceptibility  to SA1  after pretreatment,  noted by Kaliss and Day  (19): the 
mortalities  observed in the control groups are nearly as high after the second 
test graft as after the first. The control and experimental groups were slightly 
different in that different control mice were implanted  in the first and second 
tests,  while the hosts of transferred nodes which were implanted in the second 
test were the survivors of the first test. 
The  susceptibility  of  a  progressively  growing  tumor  to  destruction  by 
immunological  means  was  then  tested,  making  use  of  the  protection  con- N. A. MITCHISON AND  O. L. DUBE  191 
ferred by  transferred lymph node  cells  on pretreated  mice.  A  single  group 
of C57BR/a mice were pretreated with lyophilized A  spleen, and implanted 
with  SA1  by trocar.  At intervals after implantation minced regional lymph 
nodes were transferred to these mice from donors of the same strain  immu- 
nized with 9 day old grafts of SA1 at a dosage of 4 donors per host. The mor- 
talities in this experiment are shown in Table VI. They show that as the tumor 
TABLE V 
Duration of Immunity Conferred by Transferred Lyrapk Node Calls on Pretreated  Mice 
Implantation of SA1 in hosts pretreated with lyophili~ed  A spleen. 
Host strain 
C57BR/a.. 
~57BR/a. 
~57BR/a. 
BI0.D2 .... 
Interval from 
pretreatment 
to transfer 
-b 1st test 
days 
8 
13 
13 
6 
Interval 
between Ist 
and 2nd tests 
Mortality from test implantation of SA1 
Hosts with 
transferred cells 
1st test  2nd test 
days 
48  0/10  3/9 
2S  0/6  0/6 
9o  0/5  1/5 
96  0/5  4/6 
Hosts without 
transferred cells 
(controls) 
1st test  2nd test 
12/12 
9/10  4/6 
6/9 
S/5  4/6 
TABLE VI 
Decrease in Vulnerability of SA 1 during Progressive Growth in Pretreated  Hosts 
C57BR/a hosts pretreated with lyophilized A spleen. 
Approximate tumor  Interval between tumor implantation and receipt  Mortality from progressive  weight at time of receipt 
of lymph noae cells  growth of SA1  of lymph node cells 
days 
o 
2 
7 
17 
(No cells transferred) 
0/6 
0/6 
4/6 
6/6 
12/12 
rag 
2 
2 
8OO 
3O0O 
increased  in  size  it  became  progressively less  susceptible  to  destruction  by 
transferred cells. 
Protection  of Pretreated  Mice by Lymph Node Cells from Normal Donors 
Following again  the experimental design of Billingham, Brent, and Meda- 
war  (18),  limited  success  has  been  attained  with  protection  of  pretreated 
mice  by  transferred  normal  lymph  node  cells.  This  "replacement therapy" 
experiment is a  test of the possibility that the  transferred cells can be acti- 192  ~NOLOGICAL  RESPONSE  TO  TUMOR  TRANSPLANTs.  II 
vated immunologically by the tumor homograft, and can in turn bring about 
destruction of the tumor, although the host's own lymphoid tissue is paralyzed. 
Normal  lymph  node  cells,  transferred  immediately  before  inoculation  of 
SAI,  failed  to  protect  pretreated  mice,  as  shown  in  the  third  row of Table 
IV.  The  mortality  following  transfer  of  normal  lymph  node  cells  and  im- 
plantation  was  no  lower  than  the  mortality  following  implantation  alone. 
This  failure  can  be  accounted  for:  an  interval  must  have  elapsed  after  im- 
plantation  before  the  transferred  cells  could  have  been  activated;  during 
this interval the tumor was growing, and therefore becoming progressively less 
vulnerable. 
With the aim  of avoiding the difficulty outlined,  normal  lymph node cells were trans- 
ferred to the peritoneum  of mice of the same strain,  and a graft of SA1 was immediately 
implanted in the tail. In spite of the remoteness of the two sites, it was hoped that antigen 
from the tumor would reach the transferred  lymph node cells. 7 or 8 days later,  just before 
the tumor spread into the body, the tail was cut off. A test graft of tumor was then implanted 
in the flank, to test whether the transferred  cells had become capable of destroying the tu- 
mor. Since the prior  tail implantation  alone might have conferred some protection  on the 
mice, controls received the prior  implantation  but no transferred  lymph node cells. Addi- 
tional  controls were treated  in the same way as the experimental  group,  except that the 
transferred  cells were  donated  by  pretreated  instead  of normal  mice. 
The results  of three  such  series  are  shown  in Table  IV, fourth,  fifth,  and 
sixth  rows.  In  two  series  the  normal  cells  appeared  to  confer  marked  pro- 
tection,  with little  or no protection  in either  of the  control groups receiving 
prior  tail  implantations.  However  the  protection  could  not  be  repeated  in 
C57BL/6Ks  mice,  as  shown in  the  last  column.  The  results  taken  together, 
though  not  statistically  significant,  are  suggestive  of  a  protective  effect  of 
normal lymph node cells. 
Failure  of  Treatment  with Lyophilized  Tissue  to  Enhance  Tumor  Growth in 
Previously  Immunized  Mice 
Evidence  has  been  presented  that  graft  resistance  is  blocked by pretreat- 
ment.  The possibility  of blocking resistance  once it  has been  developed  was 
then  investigated  by  testing  the  effect  of  treatment  with  lyophilized  tissue 
on previously immunized mice. 
Ten  C57BR/a  mice were  immunized  with  SA1  implanted  by  trocar.  Lyophilized  A 
spleen was  then  injected,  commencing 25  days after  the imrmmlzi~lg implantation.  Test 
grafts  of SA1 were implanted  subsequently:  none of the mice succumbed  to the  tumor. 
These mice were treated and implanted together with the mice of the third column in Table 
IV, the pretreated  and implanted  controls showing a mortality  of 5 out of 9. 
Treatment  with  lyophilized  tissue  appears  therefore  to be unable  to block 
graft resistance in previously immunized mice. N.  A.  MITCHISON  AND  O.  L.  DUBE  193 
Localization of Transferred Lymph  Node Cells 
On  the hypothesis that  homografts are destroyed by cell-bound antibody, 
lymph node cells from an immunized donor transplanted into the peritoneum 
of secondary hosts would be expected to localize  in  a  subcutaneous homo- 
graft.  An  attempt  was made  to  follow the  fate  of transferred  lymph  node 
cells by the acriflavine  marker technique of De Bruyn, Robertson, and  Farr 
(20). This dye has the property of staining cell nuclei in vivo, and of fluoresc- 
ing in ultraviolet light.  Stained cells can therefore be picked  out by the  use 
TABLE  VII 
The Effect  of Acriflavine Staining  on the Ability of Lymph Node Cells to Transfer Immunity 
Immunity to SA1 in C57BR/a mice. 
No. of lymph  node  cells  transferred 
80  X  106 
40  X  106 
20  X  10  ° 
Weights of 8 day test tumors 
Acriflavlne  stained  lymph 
node cells 
mg. 
0.0 
0.0 
3.0 
25.4 
19.0 
77.9 
Unstained control 
cells 
mg. 
0.0 
2.4 
0.9 
4.7 
30.3 
42.9 
10  X  106 
None 
69.3 
154.9 
54.0 
89.1 
93.6 
146.3 
106.7 
188.1 
of a  suitable optical system. The light  source and filters  used in the present 
work were of the type used in  the original  report  of De Bruyn,  Robertson, 
and Farr (20). 
Preliminary experiments were carried  out to test quantitatively  the effect 
of staining  with acriflavine  on  the capacity of lymph node cells  to  transfer 
immunity. 
A group of 32 C57BR/a donors were implanted with SA1 by trocar. 9 days later the dye 
was injected intraperitoneaUy into half the group, at a  dosage of 60 reg./kilo, body weight. 
This is the approximate median lethal dose for the sample of dye used,  in  this  strain.  2 
hours after injection, when staining of the regional lymph node ceils was at a  maximum, 
the regional lymph nodes were excised, pooled, and a  suspension of cells prepared. The sus- 194  IMMUNOLOGICAL RESPONSE  TO  TUMOR  TRANSPLANTS.  II 
pension was  counted,  and  injected at  various doses into C57BR/a hosts.  A  similarly pre- 
pared unstained cell suspension  was transferred from the remaining half of the donor group. 
Both sets of hosts were then injected subcutaneously with 1  X  106 ascitic cells of SA1 sus- 
pended  in  0.1  ml.  Ringer,  and  the resulting  tumor  growths  weighed after  8  days.  These 
weights  are  shown  in  Table  VII. 
Staining  with acriflavine  appeared to have no effect on the capacity of cells 
to transfer immunity. 
FoUowing  the same staining procedure,  lymph nodes were transferred  as mince.  Smears 
of living cells from the abdominal cavity and organs of the hosts were examined at intervals 
after transfer. 2 hours after transfer stained cells could be seen in the spleen, liver, kidneys, 
lungs,  and  mediastinal  lymph  node,  but  not  in  the  thymus,  axillary,  or  inguinal  lymph 
nodes, nor in the buffy coat of the blood. Some cells were more heavily stained than others, 
making  quantitative  estimates  of  their  number  difficult.  Mter  transfer  of mince into  the 
peritoneum,  at a  dosage of 12 stained lymph nodes per host, a  rough count gave between 
1 in  100 and  1 in  1000 stained ceils in the spleen. The stain in the transferred cells faded 
slowly, disappearing overnight. Subcutaneous homografts of SA1 were searched for stained 
cells,  after  transfer  to  their  hosts  of  stained  lymph  node  ceils  from  immunized  donors. 
Marked  cells  could  not  be  found  in  the  grafts. 
This  failure  indicates  either  that  transferred  cells do not reach grafts,  or 
that they do so and are rapidly destroyed, or else that they do so too slowly 
to be detected by this  technique.  However it is clear  that  transferred  cells 
have  ample  opportunity  of passing  out  of  the  peritoneum  into  a  graft,  or 
into the lymphoid tissue of the host. 
DISCUSSION 
Lymph node cells from donors immunized by homografts have been shown 
to  transfer  hemagglutinin  production  to  secondary  hosts.  These  cells  also 
confer  heightened  graft  resistance  on  their  hosts.  This  poses  the  problem 
whether  the  hemagglutinating  antibody  itself  is  the  cause  of  heightened 
graft resistance.  The alternative hypothesis is that lymph node cells produce 
more than  one kind of antibody, the antibody effective in combating homo- 
grafts  being  distinct  from  the  hemagglutinating  antibody.  The  dual  func- 
tion  hypothesis is supported by the different timing  in lymph node cells  of 
the ability to transfer heightened graft resistance and hemagglutinin produc- 
tion. It is also supported by the findings  with lymph node cells from tumor- 
beating mice pretreated  with frozen or lyophilized tissue.  These  cells trans- 
ferred  hemagglutinin  production  but  not  graft  resistance,  indicating  that 
their ability to produce antibody effective against homografts could be blocked 
without impairing  hemagglutinin  production.  Further evidence for this block 
is provided by the transplantation  of lymph node cells into pretreated mice: 
cells  from immunized  and  possibly also from normal  donors  conferred pro- 
tection against tumor homografts. N.  A.  MITCEISON  AND  O.  L.  DUBE  195 
The failure of serum to confer heightened graft resistance in passive trans- 
fer  experiments  suggests  that  the  antibody  effective against  homografts  is 
bound to cells,  presumably lymphocytes. On this hypothesis,  ceils from im- 
munized  donors  transferred  into  secondary hosts  would  be expected  to  lo- 
calize  in a  test homograft.  The  failure  to detect this  localization  with dye- 
marked  cells is not  conclusive evidence against  cell-bound antibody because 
of the rapid fading of the dye. It may be noted that attempts to detect local- 
ization of serum isoantibody have also been unsuccessful (21). 
Further resemblances between the homograft reaction and sensitization  to 
tuberculin and  to simple  organic  compounds emerge from the present work. 
a)  Ceils which transfer delayed sensitivity have been shown by Chase also to 
transfer antibody of the anaphylactic  type (22,  23).  b) The  course of serum 
antibody production during  sensitization  does not run  parallel  to the devel- 
opment of delayed sensitivity (24).  c) Tuberculoprotein, picryl chloride,  and 
even  egg  albumen  injected  together  with  tubercle  bacillary  wax  adjuvant 
elicit delayed reactivity;  but  when  injected  alone  these agents  induce  only 
serum antibody (25-27). The adjuvant,  though not itself antigenic,  incites a 
granulomatous  response  of the  type which  has often been compared  to  the 
round  cell  infiltration  of  homografts  (28).  There  are  indications  that  the 
preparations  of  frozen  or  lyophilized  tissue  which  induce  serum  antibody 
without heightened graft resistance do not incite the granulomatous response: 
Darcy (29) reports that the cellular response to frozen homografts in the rab- 
bit  is  absent  or  greatly  delayed,  although  the  antigenic  specificity of  the 
frozen  tissue is retained,  as judged by the  reaction  provoked in  previously 
immunized  hosts.  This  evidence  therefore  suggests  that  the  failure  of lyo- 
philized  or frozen tissue to induce heightened graft resistance may be due to 
a  failure  to  incite  the  proper  granulomatous  response.  However  this  can 
hardly  be the full  explanation  of the  action  of the  tissue preparations:  the 
granulomatous response is probably not the sole basis for the action of bacil- 
lary wax; nor can the analogy account for the almost complete block in graft 
resistance brought about by the tissue preparations. 
SUMMARY 
The  relation  between serum antibody and resistance to tumor homografts 
in the mouse has been investigated. Production of serum antibody in response 
to homografts  of a  transplantable  sarcoma  (Sarcoma  1)  was demonstrated, 
by cytotoxic action on the cells of the  tumor,  and also by a  hemagglutinin 
test. The simpler and more repeatable hemagglutinin  test was further inves- 
tigated. 
Peak  hemagglutinin  titres  were reached  after the immunizing  homografts 
underwent  breakdown.  Following  transfer  of lymph  node  cells  from immu- 
nized  mice  into  hosts  of the  same  strain,  hemagglutinin  could be  detected 196  r~n~'NOLOGICAL RESPONSE TO  TU~OR  TRANSPLANTS. H 
in the host serum.  The course of its production showed that  this secondary 
antibody  was  not  elicited  by transferred  antigen,  nor  could  it  be  due  to 
transfer of preformed antibody. The cells developed the capadty to transfer 
hemagglutinin  production later  than  the power to transfer  heightened  graft 
resistance.  Spleen  cells also transferred  hemagglutinin  production,  at a  later 
stage after immunization  and  to a  lesser  extent than  cells from the regional 
lymph nodes. 
Implantation  of the sarcoma in mice pretreated with certain preparations 
of lyophilized or frozen tissue stimulated hemagglutinin production, although 
the tumor grew progressively. The regional  lymph nodes participated  in the 
response: they could transfer hemagglutinin  production into secondary hosts, 
but not graft resistance,  and indeed appeared to diminish  resistance. Lymph 
node cells from immunized donors conferred protection against the tumor on 
pretreated  mice.  Lymph  nodes from  normal  donors  also appeared  in  some 
experiments  to  confer  protection  although  the  effect was  obscured  by  the 
rapidity with which the growing  tumor became immunologically invulnerable. 
The  fate of lymph node  cells  stained  with  acriflavine  was followed after 
transfer. No effect of the staining on the power of the cells to confer immunity 
could be detected. Cells transferred to the peritoneal cavity passed into various 
host tissues, but were not found in test homografts. 
The  conclusion  is  drawn  that  the  hemagglutinating  antibody  is  distinct 
from the antibody effective in combating homografts. The similarity in this 
respect between the  homograft  reaction  and  sensitization  is  emphasized  in 
discussion. 
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